海外の治験の状況「膀胱がん」での検索結果
97件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- The uRNA study for the detection of bladder cancer
- Bladder cancer;hematuria
- Australia, New Zealand
- 2008-01-29
Not recruiting
- Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT)
- Bladder Cancer
- Egypt
- 2015-09-16
Not recruiting
- A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
- Bladder Cancer
- Australia, Austria, Belgium, Canada, Czech Republic, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Serbia, Slovenia, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-11-25
Not recruiting
- BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
- Bladder Cancer;Diabetes
- Ghana
- 2015-07-20
Recruiting
- Study of Tumour Focused Radiotherapy for Bladder Cancer
- Bladder Cancer;Bladder Cancer;Bladder Cancer;Bladder Cancer
- Australia, New Zealand, United Kingdom
- 2015-05-11
Recruiting
- Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
- Superficial Bladder Cancer;C67 - Malignant neoplasm of bladder
- Egypt, Germany
- 2015-03-04
Not Recruiting
- A comparative study of MPDL3280A versus chemotherapy in patients with advanced bladder cancer.
- Advanced tumor and metastastic disease MedDRA version: 19.1 Level: LLT Classification code 10046721 Term: Urothelial carcinoma bladder stage III System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States
- 2014-11-04
Authorised
- A Phase II Trial of MK-3475 in Subjects with Bladder Cancer
- advanced/unresectable (inoperable) or metastatic urothelial cancer of the renal pelvis, ureter, bladder, or urethra. MedDRA version: 17.1 Level: LLT Classification code 10046714 Term: Urothelial carcinoma bladder System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Denmark, Hungary, Israel, Italy, Puerto Rico, Spain, United States
- 2014-11-03
Not recruiting
- Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer
- Superficial Bladder Cancer
- Egypt, Germany
- 2013-12-05
Authorised
- A study of nivolumab in participants with metastatic or unresectable bladder cancer
- metastatic or unresectable urothelial cancer MedDRA version: 19.0 Level: LLT Classification code 10046723 Term: Urothelial carcinoma ureter System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 19.0 Level: LLT Classification code 10046714 Term: Urothelial carcinoma bladder System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 19.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 19.0 Level: PT Classification code 10005003 Term: Bladder cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 19.0 Level: LLT Classification code 10046728 Term: Urothelial carcinoma urethra System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Czech Republic, Finland, Germany, Italy, Japan, Poland, Spain, Sweden, United States
- 2014-12-11
